ClinicalTrialsFinder

Neuroendocrine Tumor Grade 2 Clinical Trials in Philadelphia, Pennsylvania

1 recruitingPhiladelphia, Pennsylvania

Showing 1–1 of 1 trials

Recruiting
Phase 2

CapTemY90 for Grade 2/3 NET Liver Metastases

Neuroendocrine TumorsNeuroendocrine Tumor Grade 2
Abramson Cancer Center at Penn Medicine70 enrolled4 locationsNCT04339036